TABLE 1.
In vitro and preclinical application of ASC-scaffold composites.
S. No. | ASC dose | Source of ASCs | Scaffold type | Model | Reference |
---|---|---|---|---|---|
1 | 2 × 106/ml | Human | Silylated chitosan and cellulose hydrogel | Canine OC defect in dogs | Boyer et al. (2020) |
2 | 0.02 × 106 cells/spheroid | Human | 3D-printed osteochondral interface using osteogenic and chondrogenic spheroid | In vitro study | Ayan et al. (2020) |
3 | 0.5 × 106 cell/40 ml | Rabbit | Porous poly (ε-caprolactone) (PCL) scaffold with different pore sizes | OC defect in femur of rabbit | Im et al. (2012) |
4 | 0.2 × 106 cells/350 μl | Human | 3D collagen gel scaffold | In vitro study | Scioli et al. (2016) |
5 | 1 × 107 cells/ml | Rabbit | Coacervate-embedded composite hydrogels | Femoral trochlear osteochondral defect in rabbit | Cho et al. (2020) |
6 | 0.25 × 106/cm2 (when 0% tricalcium phosphate used) and 0.02 × 106/cm2 (when 20% TCP used) | Human | Stacked polylactic acid nanofibrous scaffolds | In vitro study | Mellor et al. (2015) |
7 | 1 × 107 cells/ml | Human | Cancellous bone/hydrogel (chitosan/gelatin) hybrid scaffold | In vitro study | Song et al. (2016) |
8 | 2 × 106 cells | Rabbit | Cartilage extracellular matrix-derived particles (CEDPs) and cartilage slice-based scaffold | Rabbit femoral trochlear osteochondral defect | Yin et al. (2018) |
9 | 0.4 × 106 cells/30 ul | Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) | Photo-crosslinked gelatin methacryloyl (gelMA) scaffold | In vitro study | Hölzl et al. (2021) |
10 | 0.256 × 106 per microspheroids | Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) | Gelatin-based hydrogels | In vitro study | Zigon-Branc et al. (2019) |
11 | 0.25 × 106 cells for the chondrogenic layer and 0.5 × 106 cells for the osteogenic layer | Rabbit | Trilayered silk fibroin scaffolds | In vitro study | Ding et al. (2014) |
12 | 0.25 × 106 cells/scaffold | Human | Multiphasic 3D-bioplotted scaffolds | In vitro study | Mellor et al. (2020) |
13 | 2 × 106 cells/scaffold | Rabbit | Biodegradable porous sponge cartilage scaffold | Full thickness femoral defect in rabbits | Widhiyanto et al. (2020) |
14 | 0.5 × 106 cells/ml (in vivo) 5 × 103 cells/ml–0.5 × 106 cells/ml (in vitro) | Not specified | Protein-reactive nanofibrils scaffold | Articular cartilage defect | Kim et al. (2021) |
15 | 50 ul of 50 × 106 cells/ml | Rabbit | Poly(L-glutamic acid)-based scaffold | Articular osteochondral defect in rabbits | Zhang et al. (2016) |
16 | 3 × 106 cells | Minipig human | Oligo (polyethylene glycol) fumarate (OPF) hydrogel | OC defect in minipigs | De Girolamo et al. (2015) |
17 | 0.5 × 106 cells | Rabbit | Immobilized porous polycaprolactone scaffold | Distal femur OC defect in rabbits | Im and Lee, (2010) |
18 | 0.25 × 106 co-cultured cells with human articular chondrocytes | Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) | AuriScaff (auricular cartilage scaffold) | OC plug model in mice | Nürnberger et al. (2019) |
19 | 0.075 × 106 and 0.15 × 106 cells | Pig ASCs | Multiphasic 3D-bioplotted scaffold | OC defects in minipigs | Nordberg et al. (2021) |